Collaborative and remote monitoring to do the rounds of the Lipopolysaccharides Immunoassay Market, reaching US$ 1.9 Bn

The lipopolysaccharides immunoassay market was worth US$ 1.3 Bn at the end of 2021 and is expected to increase at a CAGR of 3.2% over the forecast period (2022-2032).

The growing threat of infection proliferation and spread, as well the emergence of a pandemic has proposed a great need for lipopolysaccharides immunoassay kits and reagents. Early detection of zoonotic disease spread is beneficial to community health and overall wellness.

Although the occurrence of a natural infection is relatively infrequent in humans, yet, diseases such as tularaemia pose a severe potential hazard to public health due to their persistence in water supplies, arthropod vectors, and animal reservoirs, as well as their low degree of clinical detection. PCR, serological assays, and bacterial culture of patient samples are some of the current diagnostic methods; however, these methods take time and call for technical knowledge that might not be readily available at the point of care. A more sensitive diagnostic platform is necessary in the event of an outbreak or exposure.

Want Insights To Lipopolysaccharides Immunoassay Market? Ask For Sample! https://www.persistencemarketresearch.com/samples/33143

Growing adoption of lipopolysaccharides immunoassay kits for the detection of such potentially lethal zoonotic diseases caused by intracellular gram-negative bacteria will provide a boost to the growth of the lipopolysaccharides immunoassay market over the years.

Moreover, with the need for analytical technology on the rise, the development of immunoassay test kits is expected to surge due to growing awareness among the general population in terms of infection prevention and control.

Key Takeaways from Market Study

Immunoassay kits & reagents held around 64% market share by product type in 2021.

By assay, LFA held around 39% of the global lipopolysaccharides immunoassay market share in 2021.

By purpose, clinical use account for 82.2% of the global market share in 2021.

Clinical purpose by application held around 66.4% of the global market share in 2021.

By end user, human use accounted for the highest market share value of 91.4% in 2021.

Around 31.6% of the global market share, by region, was accounted for by North America in 2021.

"Growing disease burden combined with emergence of the COVID-19 pandemic, as well as increasing adoption of immunoassay test kits around the world, will drive market growth," says an analyst of Persistence Market Research.

To receive an extensive list of important regions, ask for a Table of Content https://www.persistencemarketresearch.com/market-research/lipopolysaccharides-immunoassay-market/toc

Market Competition

Key players in the market strive to approach target consumers with effective strategies such as the provision of kits enabling early detection of disease pathogens.

With the provision of viable products that are valuable to patient care, key players within the market are incorporating new product development strategies such as product patenting and licensing.

In December 2018, Thermo Fisher Scientific received FDA clearance for its de novo submission of the Thermo Scientific QMS Plazomicin Immunoassay, the first of its kind for complementary diagnostic immunoassays.

In February 2021, Bio-Techne Corporation announced that ProteinSimple, a Bio-Techne brand, expanded its Simple PlexTM immunoassay cartridge portfolio to include nine new cartridge formats.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the lipopolysaccharides immunoassay market in its latest study, presenting a historical demand assessment of 2012 - 2021 and projections for 2022 - 2032.

The research study is based on the product type (immunoassay kits & reagents [kits, primary antibodies, secondary antibodies, immunoassay substrates, and immunoassay buffers], analysers & instruments, consumables, and software), assay (ELISA, FIA, CLIA, LFA, and others), purpose (research use only and clinical use), application (clinical diagnostics, drug discovery, and screening of diseases & disorders), and end user (biopharmaceutical companies, contract manufacturing organizations, contract research organizations, and research & academic institutes), across seven key regions of the world.

How About Knowing The Product/Technology Driving TheLipopolysaccharides Immunoassay Market Before Investing Therein? Click The "Purchase Now" Button Of Our Lipopolysaccharides Immunoassay Market Report https://www.persistencemarketresearch.com/checkout/33143

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.